Global market for drugs expected to hit all time high in 2014And IMS Health predicts market will exceed $1.17 trillion by 2017. Budget 2014 demonstrates support for Canadian Research and Innovation ICGC releases cancer genome data India's Ranbaxy hit by FDA product ban at 4th Indian plant The FDA says company can’t use ingredients from facility in generic drugs marketed in the U.S. Investment lessons from a Nobel Prize winner Thinking small can lead to big gains SDI Canada buys SDI U.S.A. Montreal firm specializing in MRI shielding solutions to expand to numerous new global healthcare markets 'Historic agreement' gives Canada more med school autonomy Agreement still preserves reciprocity between the U.S. and Canada Rx&D responds to story about drug spending down Canada’s drug R&D spending down The last word: Healthier, wealthier, smarter That’s the new bottom line for investment in health research First Previous 28 29 30 31 32 Next Last
